The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.
Chitra JosephMansour A AlsaleemMichael S TossYousif A KaririMaryam AlthobitiSami AlsaeedAbrar I AljohaniPavan L NarasimhaNigel P MonganAndrew R GreenEmad A RakhaPublished in: Cancers (2020)
High expression of LAIR-1 is associated with poor clinical outcome in BC. Association with immune cells and immune checkpoint markers warrant further studies to assess the underlying mechanistic roles.